newsfilter
← Latest News
GlobeNewswire·

Autonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform

Newly Issued Patent Expands Company's Neural Sensing Technology Platform into Large Urology Market Affecting Approximately 37 Million Americans THE WOODLANDS, TX, July 15, 2026 (GLOBE NEWSWIRE) -- Autonomix